NOS2 and neoplasm: Inhibition of CBP/EP300-BRD redirected tumor-associated MDSCs from inhibitory phenotype to inflammatory phenotype by down-regulating the genes associated with the STAT pathway and inhibiting Arg-1 and iNOS [91].